drugset / Trial / NCT00820144
Cholera Toxin B Subunit (CTB) Administered by Mucosal Way in Healthy Adult Volunteer
RandomizedFactorialOpen-labelBasic science
Summary
It is a biomedical research without direct individual benefit, exploring and comparing the mucosal immune response after oral, nasal and sublingual administration of B-subunit of non-toxic cholera toxin (CTB) in healthy adult volunteers.
Timeline
- Start
- 2006-04
- Primary completion
- 2006-04
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | B-subunit of non-toxic cholera toxin | Protein / enzyme biologic | 0.25 mg | Intranasal |
| Subject | B-subunit of non-toxic cholera toxin | Protein / enzyme biologic | 0.5 mg | Intranasal |
| Subject | B-subunit of non-toxic cholera toxin | Protein / enzyme biologic | 1 mg | Intranasal |
| Subject | Shanchol | Vaccine | 1 mg | Oral |